ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Thermo Fisher Scientific has completed its $13.6 billion acquisition of Life Technologies. The Federal Trade Commission granted the final approval after requiring Thermo Fisher to divest its cell culture (sera and media), gene modulation (siRNA reagents), and magnetic beads businesses. In early January, Thermo Fisher had agreed to sell the three businesses to GE Healthcare for $1.1 billion to satisfy European regulators. Life Technologies is now part of a new Thermo Fisher business called Life Sciences Solutions, headed by former Life Tech Chief Operating Officer Mark Stevenson.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter